Literature DB >> 11202086

National audit of the management and outcome of carcinoma of the cervix treated with radiotherapy in 1993.

A S Denton1, S J Bond, S Matthews, S M Bentzen, E J Maher.   

Abstract

The aim of the study was to investigate the UK prevalence of late, severe side-effects associated with radical radiotherapy for cancer of the cervix and try to identify associated factors. All patients treated for cancer of the cervix with radical radiotherapy in 1993 were identified and retrospective case notes studied to determine mortality and severe complications occurring following treatment. Of the 55 radiotherapy departments in the UK that were treating gynaecological malignancy in 1993, 53 participated in the study. There were 1558 patients with carcinoma of the cervix receiving radical radiotherapy as part of their treatment regimen in 1993, whose patterns of treatment were assessed. The main outcome measures were the development of late severe complications as defined by the Franco-Italian Glossary and mortality. Of the patients receiving surgery and radiotherapy, 58.5% underwent Wertheim's procedure. The crude rate of late severe complications in all patients with cervical cancer treated with radical radiotherapy in 1993 was 6.1% (actuarial rate 8%) at 5 years, and only four of the 91 patients who developed complications died as a result of their morbidity. There was no significant correlation of stage, centre size, surgery or radiotherapeutic approach with late morbidity in univariate analysis. The overall survival at 5 years was 47% and was lower than that of the European data from FIGO's 1990-92 cohort, for all stages. Increasing FIGO stage was the only factor significantly associated with mortality. The absence of variables that were significantly associated with late complications may well be related to the relatively low event rate compared to the sample size. Differences in surgical treatment prior to radiotherapy and radiation technique may be confounding the comparison of outcomes. The relatively poor survival for locally advanced disease and the difficulty with which these data were collated indicates that national prospective data collection is urgently required to monitor performance and hence derive best practice.

Entities:  

Mesh:

Year:  2000        PMID: 11202086     DOI: 10.1053/clon.2000.9192

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  19 in total

Review 1.  Vaginal dilator therapy for women receiving pelvic radiotherapy.

Authors:  Tracie Miles; Nick Johnson
Journal:  Cochrane Database Syst Rev       Date:  2014-09-08

2.  Gastrointestinal complications of pelvic radiotherapy: are they of any importance?

Authors:  J Andreyev
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

3.  The utility of hyperbaric oxygen therapy to treat recurrent acute bowel obstruction after previous pelvic radiotherapy: a case series.

Authors:  M J Abu-Asi; H J N Andreyev
Journal:  Support Care Cancer       Date:  2013-04-27       Impact factor: 3.603

Review 4.  Vaginal dilator therapy for women receiving pelvic radiotherapy.

Authors:  Tracie Miles; Nick Johnson
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

5.  Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients.

Authors:  Imjai Chitapanarux; Taned Chitapanarux; Patrinee Traisathit; Sudkaneung Kudumpee; Ekkasit Tharavichitkul; Vicharn Lorvidhaya
Journal:  Radiat Oncol       Date:  2010-05-05       Impact factor: 3.481

Review 6.  Gastrointestinal radiation injury: symptoms, risk factors and mechanisms.

Authors:  Abobakr K Shadad; Frank J Sullivan; Joseph D Martin; Laurence J Egan
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

7.  Modelling the influence of treatment time on the biological effectiveness of single radiosurgery treatments: derivation of "protective" dose modification factors.

Authors:  Bleddyn Jones; John W Hopewell
Journal:  Br J Radiol       Date:  2018-08-21       Impact factor: 3.039

8.  Substantial improvement in UK cervical cancer survival with chemoradiotherapy: results of a Royal College of Radiologists' audit.

Authors:  C L Vale; J F Tierney; S E Davidson; K J Drinkwater; P Symonds
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-07-01       Impact factor: 4.126

9.  Assessment of treatment-induced female sexual morbidity in oncology: is this a part of routine medical follow-up after radical pelvic radiotherapy?

Authors:  I D White; H Allan; S Faithfull
Journal:  Br J Cancer       Date:  2011-09-06       Impact factor: 7.640

10.  Health-related quality of life and late morbidity in concurrent chemoradiation and radiotherapy alone in patients with locally advanced cervical carcinoma.

Authors:  Maaike J Berveling; Johannes A Langendijk; Jannet C Beukema; Marian J E Mourits; Anna K L Reyners; Elisabeth Pras
Journal:  J Gynecol Oncol       Date:  2011-09-28       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.